Spirendolol

{{Chembox

| ImageFile = Spirendolol.svg

| ImageSize = 200px

| ImageAlt =

| IUPACName = 4-[3-(tert-Butylamino)-2-hydroxypropoxy]spiro[3H-indene-2,1'-cyclohexane]-1-one

| OtherNames =

|Section1={{Chembox Identifiers

| CASNo = 65429-87-0

| CASNo_Ref = {{cascite|correct|CAS}}

| UNII = 96789094BR

| UNII_Ref = {{fdacite|correct|FDA}}

| PubChem = 68857

| ChemSpiderID = 62090

| InChI = 1/C21H31NO3/c1-20(2,3)22-13-15(23)14-25-18-9-7-8-16-17(18)12-21(19(16)24)10-5-4-6-11-21/h7-9,15,22-23H,4-6,10-14H2,1-3H3

| InChIKey = YLBMSIZZTJEEIO-UHFFFAOYAB

| StdInChI = 1S/C21H31NO3/c1-20(2,3)22-13-15(23)14-25-18-9-7-8-16-17(18)12-21(19(16)24)10-5-4-6-11-21/h7-9,15,22-23H,4-6,10-14H2,1-3H3

| StdInChIKey = YLBMSIZZTJEEIO-UHFFFAOYSA-N

| SMILES =CC(C)(C)NCC(COC1=CC=CC2=C1CC3(C2=O)CCCCC3)O }}

|Section2={{Chembox Properties

| C=21 | H=31 | N=1 | O=3

| Appearance =

| Density =

| MeltingPt =

| BoilingPt =

| Solubility = }}

|Section3={{Chembox Hazards

| MainHazards =

| FlashPt =

| AutoignitionPt = }}

}}

Spirendolol is a beta adrenergic receptor antagonist.{{cite journal|pmid=2879033|year=1986|last1=Mostaghim|first1=R|last2=Maddox|first2=YT|last3=Ramwell|first3=PW|title=Endothelial potentiation of relaxation response to beta adrenoceptor blocking agents|volume=239|issue=3|pages=797–801|journal=The Journal of Pharmacology and Experimental Therapeutics}}